Search results
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 6 days agoRicks is determined to avoid the mistake that the company made with a blockbuster drug decades...
Amazon's Affordable Pharmacy program rxPass opens up to Medicare users with Prime
Engadget· 2 days agoNow, Amazon is expanding the program to Prime members on Medicare insurance, opening eligibility up...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 18 hours agoInvestment Research Skyrizi is a key top-line driver for AbbVie. The drug generated sales of $2.01...
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation
Motley Fool via Yahoo Finance· 2 days agoThe Motley Fool has positions in and recommends Apple, Costco Wholesale, and Vertex Pharmaceuticals....
Gateway - Quartz
Quartz· 2 days agoPharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. Although biosimilars will sell at a ...
What Makes Corcept Therapeutics (CORT) a Good Investment Bet?
Insider Monkey via Yahoo Finance· 19 hours agoClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value...
4 Stocks to Buy Amid Dental Supplies Industry Challenges
Zacks via Yahoo Finance· 6 days agoHowever, inflationary pressure continues to hurt margins. The company expects adjusted earnings per...
FDA Issues Warning Letter To Toltrazuril Shop Over Sale Of EPM Medication
Paulick Report· 6 days agoThe U.S. Food and Drug Administration has issued a warning letter to the web-based business Toltrazuril Shop, informing the company's management that "introducing ...
Opinion | It’s Time to Ban Pharmaceutical Advertising
New York Times· 18 hours agoSeeing that phrase on my screen as I idly scrolled TikTok made me stop and watch the whole video,...
McKesson (MCK) Gains 26% YTD: What's Driving the Rally?
Zacks via Yahoo Finance· 7 days agoMcKesson's (MCK) shares have risen year to date on the back of strong fundamentals. Rising volumes...